Literature DB >> 4064374

Role of lymphocyte blastogenesis to Toxoplasma gondii antigens in containment of chronic, latent T. gondii infection in humans.

R McLeod, R G Estes.   

Abstract

Lymphocyte blastogenic transformation in response to Toxoplasma lysate antigen was markedly impaired in six of eight patients with chronic, latent Toxoplasma gondii infection and treated Hodgkin's disease. None of these patients with serum antibody to T. gondii measured by the Sabin Feldman Dye test and impaired lymphocyte transformation to T. gondii antigens had clinical or serologic evidence of disseminated, active infection with T. gondii. Partial depletion of adherent mononuclear leukocytes improved the impaired lymphocyte transformation of three of six patients; treatment of cultures from all patients with indomethacin improved their blastogenic transformation but culture with normal heterologous serum did not. These studies indicate that lymphocyte blastogenic response to T. gondii antigens is impaired in some patients with chronic, latent T. gondii infection and treated Hodgkin's disease but that this impairment of lymphocyte function is not sufficient to cause reactivation of chronic, latent T. gondii infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4064374      PMCID: PMC1577415     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Ocular toxoplasmosis; pathogenesis, diagnosis and treatment.

Authors:  J K FRENKEL; L JACOBS
Journal:  AMA Arch Ophthalmol       Date:  1958-02

2.  Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products.

Authors:  S E Anderson; S Bautista; J S Remington
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

Review 3.  Influence of infection with Toxoplasma on macrophage function, and role of macrophages in resistance to Toxoplasma.

Authors:  R McLeod; J S Remington
Journal:  Am J Trop Med Hyg       Date:  1977-11       Impact factor: 2.345

4.  Toxoplasmosis complicating malignancy. Experience at the National Cancer Institute.

Authors:  W M Vietzke; A H Gelderman; P M Grimley; M P Valsamis
Journal:  Cancer       Date:  1968-05       Impact factor: 6.860

5.  Deficiency of lymphocyte antigen recognition in Hodgkin's disease.

Authors:  J D Gaines; M A Gilmer; J S Remington
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

6.  Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.

Authors:  W L Sibbitt; A D Bankhurst; R C Williams
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

7.  A method to evaluate the capacity of monocytes and macrophages to inhibit multiplication of an intracellular pathogen.

Authors:  R McLeod; J S Remington
Journal:  J Immunol Methods       Date:  1979-05-10       Impact factor: 2.303

Review 8.  Toxoplasmosis in the compromised host.

Authors:  J Ruskin; J S Remington
Journal:  Ann Intern Med       Date:  1976-02       Impact factor: 25.391

9.  Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products.

Authors:  J S Borges; W D Johnson
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

10.  Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens.

Authors:  C B Wilson; V Tsai; J S Remington
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  6 in total

1.  Prevention of peroral and congenital acquisition of Toxoplasma gondii by antibody and activated macrophages.

Authors:  P Eisenhauer; D G Mack; R McLeod
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

2.  Immunological response in experimentally reactivated toxoplasmosis in mice.

Authors:  M Goyal; N K Ganguly; R C Mahajan
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

3.  Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates.

Authors:  E Candolfi; C A Hunter; J S Remington
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice.

Authors:  T Chardès; F Velge-Roussel; P Mevelec; M N Mevelec; D Buzoni-Gatel; D Bout
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

5.  Cytotoxic activity of monocytes against Toxoplasma gondii in acute, chronic and reactivated murine toxoplasmosis.

Authors:  M Goyal; N K Ganguly; R C Mahajan
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

6.  Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis.

Authors:  E Candolfi; C A Hunter; J S Remington
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.